81 related articles for article (PubMed ID: 14499798)
21. Ribavirin/interferon-alpha sequential treatment of recurrent hepatitis C after liver transplantation.
Giostra E; Kullak-Ublick GA; Keller W; Fried R; Vanlemmens C; Kraehenbuhl S; Locher S; Egger HP; Clavien PA; Hadengue A; Mentha G; Morel P; Negro F
Transpl Int; 2004 May; 17(4):169-76. PubMed ID: 15060764
[TBL] [Abstract][Full Text] [Related]
22. Randomized trial of three different regimens for 24 weeks for re-treatment of chronic hepatitis C patients who failed to respond to interferon-alpha monotherapy in Taiwan.
Chuang WL; Dai CY; Chen SC; Lee LP; Lin ZY; Hsieh MY; Wang LY; Yu ML; Chang WY
Liver Int; 2004 Dec; 24(6):595-602. PubMed ID: 15566510
[TBL] [Abstract][Full Text] [Related]
23. Successful treatment with peginterferon and ribavirin in a patient with acute hepatitis C evolving into chronicity.
Hsieh TH; Kao JH; Lai MY; Chen PJ; Chen DS
J Formos Med Assoc; 2005 May; 104(5):354-8. PubMed ID: 15959603
[TBL] [Abstract][Full Text] [Related]
24. Interferon plus ribavirin in patients with hepatitis C virus positive mixed cryoglobulinemia resistant to interferon.
Mazzaro C; Zorat F; Comar C; Nascimben F; Bianchini D; Baracetti S; Donada C; Donadon V; Pozzato G
J Rheumatol; 2003 Aug; 30(8):1775-81. PubMed ID: 12913934
[TBL] [Abstract][Full Text] [Related]
25. [Hepatitis C. Chronic hepatitis. Outcome and treatment].
Hierro Llanillo L;
An Pediatr (Barc); 2003 May; 58(5):489-91. PubMed ID: 12724085
[No Abstract] [Full Text] [Related]
26. Treatment of transfusion-dependent thalassemic patients infected with hepatitis C virus with interferon alpha-2b and ribavirin.
Sherker AH; Senosier M; Kermack D
Hepatology; 2003 Jan; 37(1):223. PubMed ID: 12500209
[No Abstract] [Full Text] [Related]
27. Peginterferon alfa-2b plus ribavirin for the treatment of hepatitis C recurrence following combined liver and kidney transplantation.
Schmitz V; Kiessling A; Bahra M; Puhl G; Kahl A; Berg T; Neuhaus R; Neuhaus P; Neumann U
Ann Transplant; 2007; 12(3):22-7. PubMed ID: 18290566
[TBL] [Abstract][Full Text] [Related]
28. Development of sarcoidosis during interferon alpha 2b and ribavirin combination therapy for chronic hepatitis C--a case report and review of the literature.
Bolukbas C; Bolukbas FF; Kebdir T; Canayaz L; Dalay AR; Kilic G; Ovunc O
Acta Gastroenterol Belg; 2005; 68(4):432-4. PubMed ID: 16432996
[TBL] [Abstract][Full Text] [Related]
29. Impact of peginterferon alpha-2b and ribavirin treatment on liver tissue in patients with HCV or HCV-HIV co-infection.
Sarmento-Castro R; Horta A; Vasconcelos O; Coelho H; Mendez J; Tavares AP; Seabra J; Duarte M; Chaves L; Fortes O; Recalde C; Ventura A; Pires N; Pinho L; Dias N; Carneiro F
J Infect; 2007 Jun; 54(6):609-16. PubMed ID: 17194480
[TBL] [Abstract][Full Text] [Related]
30. Interferon alpha 2b and ribavirin for the treatment of recurrent hepatitis C after liver transplantation: cohort study of 38 patients.
Mukherjee S; Lyden E; McCashland TM; Schafer DF
J Gastroenterol Hepatol; 2005 Feb; 20(2):198-203. PubMed ID: 15683421
[TBL] [Abstract][Full Text] [Related]
31. [Acute hepatitis C].
Kryczka W
Przegl Epidemiol; 2002; 56 Suppl 5():54-61. PubMed ID: 15553073
[TBL] [Abstract][Full Text] [Related]
32. Cost-effectiveness of peginterferon alfa-2a (40kDa) plus ribavirin in patients with HIV and hepatitis C virus co-infection.
Hornberger J; Torriani FJ; Dieterich DT; Bräu N; Sulkowski MS; Torres MR; Green J; Patel K
J Clin Virol; 2006 Aug; 36(4):283-91. PubMed ID: 16765638
[TBL] [Abstract][Full Text] [Related]
33. [Epidemic outbreak of acute hepatitis C--clinical course, histology and effectiveness of therapy].
Cianciara J; Jabłońska J; Horban A; Walewska-Zielecka B
Przegl Epidemiol; 2005; 59(2):385-94. PubMed ID: 16190545
[TBL] [Abstract][Full Text] [Related]
34. [Hepatitis C therapy is not pleasant. Patients must be prepared!].
MMW Fortschr Med; 2003 Jan; 145(3-4):57. PubMed ID: 12619237
[No Abstract] [Full Text] [Related]
35. [What are the indications for treatment of acute hepatitis C?].
Myers RP; Regimbeau C; Moussalli J; Ratziu V; Di Martino V; Thabut D; Bernard B; Benhamou Y; Poynard T
Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B188-93. PubMed ID: 12180287
[No Abstract] [Full Text] [Related]
36. [Interferon therapy for hepatitis B and C].
Iino S
Nihon Rinsho; 2007 Feb; 65 Suppl 2 Pt. 1():559-63. PubMed ID: 17455681
[No Abstract] [Full Text] [Related]
37. Effect of treatment with peginterferon or interferon alfa-2b and ribavirin on steatosis in patients infected with hepatitis C.
Poynard T; Ratziu V; McHutchison J; Manns M; Goodman Z; Zeuzem S; Younossi Z; Albrecht J
Hepatology; 2003 Jul; 38(1):75-85. PubMed ID: 12829989
[TBL] [Abstract][Full Text] [Related]
38. Current management of hepatitis C in New Zealand.
Gane E
N Z Med J; 2001 Mar; 114(1128):101-2. PubMed ID: 11346152
[No Abstract] [Full Text] [Related]
39. [High dosage induction brings new hope].
MMW Fortschr Med; 2005 Dec; 147(51-52):68. PubMed ID: 16404784
[No Abstract] [Full Text] [Related]
40. A pilot study of interferon alfa and ribavirin combination in liver transplant recipients with recurrent hepatitis C.
Shakil AO; McGuire B; Crippin J; Teperman L; Demetris AJ; Conjeevaram H; Gish R; Kwo P; Balan V; Wright TL; Brass C; Rakela J
Hepatology; 2002 Nov; 36(5):1253-8. PubMed ID: 12395337
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
